EVALUATION OF SALVAGE INDUCTION CHEMOTHERAPY REGIMENS IN MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA AFTER HYPOMETHYLATING AGENT TREATMENT FAILURE

B Ball; R Komrokji; L Ades; M Sekeres; A DeZern; Lisa Pleyer; N Vey; A Almeida; U Germing; T Cluzeau; U Platzbecker; S Gore; P Fenaux; T Prebet

EVALUATION OF SALVAGE INDUCTION CHEMOTHERAPY REGIMENS IN MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA AFTER HYPOMETHYLATING AGENT TREATMENT FAILURE

B Ball, R Komrokji, L Ades, M Sekeres, A DeZern, Lisa Pleyer, N Vey, A Almeida, U Germing, T Cluzeau, U Platzbecker, S Gore, P Fenaux, T Prebet

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	S58-S59
Journal	LEUKEMIA RESEARCH
Volume	55
Publication status	Published - 2017
Event	14th International Symposium on Myelodysplastic Syndromes (MDS) - Valencia, SPAIN Duration: 3 May 2017 → 6 May 2017

Cite this

Ball, B., Komrokji, R., Ades, L., Sekeres, M., DeZern, A., Pleyer, L., Vey, N., Almeida, A., Germing, U., Cluzeau, T., Platzbecker, U., Gore, S., Fenaux, P., & Prebet, T. (2017). EVALUATION OF SALVAGE INDUCTION CHEMOTHERAPY REGIMENS IN MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA AFTER HYPOMETHYLATING AGENT TREATMENT FAILURE. LEUKEMIA RESEARCH , 55, S58-S59.

Ball, B ; Komrokji, R ; Ades, L et al. / EVALUATION OF SALVAGE INDUCTION CHEMOTHERAPY REGIMENS IN MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA AFTER HYPOMETHYLATING AGENT TREATMENT FAILURE. In: LEUKEMIA RESEARCH 2017 ; Vol. 55. pp. S58-S59.

@article{7bd1bf81382947dfa83850325fb51386,

title = "EVALUATION OF SALVAGE INDUCTION CHEMOTHERAPY REGIMENS IN MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA AFTER HYPOMETHYLATING AGENT TREATMENT FAILURE",

author = "B Ball and R Komrokji and L Ades and M Sekeres and A DeZern and Lisa Pleyer and N Vey and A Almeida and U Germing and T Cluzeau and U Platzbecker and S Gore and P Fenaux and T Prebet",

year = "2017",

language = "English",

volume = "55",

pages = "S58--S59",

journal = "LEUKEMIA RESEARCH ",

issn = "0145-2126",

note = "14th International Symposium on Myelodysplastic Syndromes (MDS) ; Conference date: 03-05-2017 Through 06-05-2017",

}

Ball, B, Komrokji, R, Ades, L, Sekeres, M, DeZern, A, Pleyer, L, Vey, N, Almeida, A, Germing, U, Cluzeau, T, Platzbecker, U, Gore, S, Fenaux, P & Prebet, T 2017, 'EVALUATION OF SALVAGE INDUCTION CHEMOTHERAPY REGIMENS IN MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA AFTER HYPOMETHYLATING AGENT TREATMENT FAILURE', LEUKEMIA RESEARCH , vol. 55, pp. S58-S59.

EVALUATION OF SALVAGE INDUCTION CHEMOTHERAPY REGIMENS IN MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA AFTER HYPOMETHYLATING AGENT TREATMENT FAILURE. / Ball, B; Komrokji, R; Ades, L et al.
In: LEUKEMIA RESEARCH , Vol. 55, 2017, p. S58-S59.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - EVALUATION OF SALVAGE INDUCTION CHEMOTHERAPY REGIMENS IN MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA AFTER HYPOMETHYLATING AGENT TREATMENT FAILURE

AU - Ball, B

AU - Komrokji, R

AU - Ades, L

AU - Sekeres, M

AU - DeZern, A

AU - Pleyer, Lisa

AU - Vey, N

AU - Almeida, A

AU - Germing, U

AU - Cluzeau, T

AU - Platzbecker, U

AU - Gore, S

AU - Fenaux, P

AU - Prebet, T

PY - 2017

Y1 - 2017

M3 - Abstract (Journal)

SN - 0145-2126

VL - 55

SP - S58-S59

JO - LEUKEMIA RESEARCH

JF - LEUKEMIA RESEARCH

T2 - 14th International Symposium on Myelodysplastic Syndromes (MDS)

Y2 - 3 May 2017 through 6 May 2017

ER -

Ball B, Komrokji R, Ades L, Sekeres M, DeZern A, Pleyer L et al. EVALUATION OF SALVAGE INDUCTION CHEMOTHERAPY REGIMENS IN MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA AFTER HYPOMETHYLATING AGENT TREATMENT FAILURE. LEUKEMIA RESEARCH . 2017;55:S58-S59.